Independent resource
About
Kestara is an independent resource for navigating ibogaine clinical-trial enrollment. It exists to make practical questions easier to locate, understand, and verify without presenting itself as a provider of care.
Why Kestara exists
Clear ground for careful choices.
Kestara helps adults and supporters understand the practical steps, eligibility questions, risks, and obligations involved in regulated ibogaine-related clinical research. The resource distinguishes research participation from commercial treatment and encourages verification through official study records and sponsors.
Our work is organized to support orientation rather than persuasion. The enrollment guidance collected across Kestara is designed to help readers identify what is being asked, what information should be checked, and where uncertainty still belongs.
We also recognize that people may encounter many different claims while looking for information. Context matters: comparisons with treatment-center options should not be mistaken for a study listing, and questions about legal status in a particular setting require verification from appropriate official sources.
Our editorial approach
Traceable, plainspoken, and careful.
We prioritize official registries, study sponsors, published literature, and other primary or established reference sources. Clinical study records are intended to provide structured information about research studies; the ClinicalTrials.gov study registry is one place readers can independently check a record and its listed contacts or eligibility details.
When a source does not answer a practical question, we say so. We do not fill gaps with assumptions, and we separate what a source states from what a reader may still need to clarify with a study team.
“Verification is part of informed choice.”
What we cover
Useful structure, not a substitute for judgment.
Kestara organizes general information around practical enrollment questions, study records, safety-oriented preparation, and the limits of independent guidance. The ways Kestara organizes its guidance reflect that purpose: provide an understandable starting point while leaving medical, legal, and enrollment decisions to the appropriate parties.
Readers may come across information connected to European treatment settings or accounts of local treatment options in Seattle. Those materials may be relevant to a person’s broader research, but they are not interchangeable with regulated study information.
For general terminology and historical context, we favor sources that can be inspected directly. For example, the National Center for Biotechnology Information provides access to biomedical literature and related research resources; it does not turn general information into individualized advice.
Principles
What guides the resource.
- Safety first: uncertain or potentially consequential information deserves careful verification.
- Plain language: practical terms should be understandable without overstating certainty.
- Independence: Kestara does not represent a clinic, medical provider, or licensed treatment center.
- Evidence awareness: primary records and established sources carry more weight than promotional claims.
- Informed choice: people should have space to ask questions and consider their own circumstances.
That distinction remains important when readers encounter discussion of magnesium-related considerations or information associated with Gabon and ibogaine context. Kestara presents information for orientation and encourages readers to confirm relevant details with official sources and qualified professionals.
Research participation is governed by processes intended to protect participants and document consent. The U.S. federal protections for human research participants describe a formal framework, though individual studies and jurisdictions can differ.
Independent by design
Information should make room for questions.
Kestara is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. We do not make enrollment decisions, assess personal eligibility, or provide treatment recommendations.